Clinical evaluation of the efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency of the lower limbs

Angiology

Volumn 53, Issue 5, 2002, Pages 539-544

  Arceo, Adalberto ^a   Berber, Arturo ^a   Treviño, Carlos ^a  

^a BASF Mexicana SA de CV   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DOBESILATE CALCIUM;

ADULT; ANKLE; ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; GASTRITIS; HEADACHE; HEARTBURN; HUMAN; LEG; LEG CRAMP; LEG PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; VEIN INSUFFICIENCY; VERTIGO;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CALCIUM DOBESILATE; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; FEMALE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; SAFETY; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 0036741441     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970205300506     Document Type: Article

References (52)

1. Mandar G, Widmer LK: Varicose veins and chronic venous insufficiency; prevalence and medical importance. In: Phlebologie 1983, ed. by Davy A, van der Stricht J. Brussels: Med Media Int, 1984, p 397.
2. Widmer LK: Basle Study III. In: Peripheral Venous Disorders, ed. by Widmer LK. Bern: Hans Huber, 1978, pp 46-49.
3. Evans CJ, Fowkes FG, Ruckley CV, et al: Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 53:149-153, 1999.
4. Carpentier PH: Epidemiology and physiopathology of chronic venous leg diseases. Rev Pract 50:1176-1181, 2000.
5. Beebe HG, Bergan JJ, Bergqvist D, et al: Classification and grading of chronic venous disease in the lower limbs-a consensus statement. Vasa 24:313-318, 1995.
6. Fagrell B: Vital microscopy and the pathophysiology of deep venous insufficiency. Int Angiol 14(suppl 1):18-22, 1995.
7. Junger M, Hahn M, Klyscz T, et al: Microangiopathy in the pathogenesis of chronic venous insufficiency. Curr Probl Dermatol 27:124-129, 1999.
8. Mortimer PS: Implications of the lymphatic system in CVI-associated edema. Angiology 51:3-7, 2000.
9. Hobbs JT: Varicose veins. Br Med J 303:707-710, 1991.
10. Walsh JC, Bergan JJ, Beeman S, et al: Femoral venous reflux abolished by greater saphenous vein stripping. Ann Vasc Surg 8:566-570, 1994.
11. Waldermann F, Hartmann M: Saphenous vein stripping in post-thrombotic syndrome. Wien Med Wochenschr 144:253-255, 1994.
12. Scriven JM, Hartshorne T, Thrush A, et al: Role of saphenous vein surgery in the treatment of venous ulceration. Br J Surg 85:781-784, 1998.
13. Perrin M: Surgical repair of varicose veins of the lower limbs by saphenous vein stripping. Ann Chir 51:735-744, 1997.
14. Padberg FT Jr: Endoscopic subfascial perforating vein ligation: Its complementary role in the surgical management of chronic venous insufficiency. Ann Vasc Surg 13:343-354, 1999.
15. Padberg FT Jr: Surgical intervention in venous ulceration. Cardiovasc Surg 7:83-90, 1999.
16. Belcaro G, Nicolaides AN, Ricci A, et al: Endovascular sclerotherapy, surgery, and surgery plus sclerotherapy in superficial venous incompetence: A randomized, 10-year follow-up trial-final results. Angiology 54:529-534, 2000.
17. Guex JJ: Ultrasound guided sclerotherapy (USGS) for perforating veins. Hawaii Med J 59:261-262, 2000.
18. Malouf GM: Ambulatory venous surgery versus sclerotherapy. Hawaii Med J 59:248-249, 2000.
19. Motykie GD, Caprini JA, Arcelus JI, et al: Evaluation of therapeutic compression stockings in the treatment of chronic venous insufficiency. Dermatol Surg 25:116-120, 1999.
20. Van Geest AJ, Veraart JC, Nelemans P, et al: The effect of medical elastic compression stockings with different slope values on edema. Measurements underneath three different types of stockings. Dermatol Surg 26:244-247, 2000.
21. Boada J, Nazco J: Clinical effectiveness of venotonic drugs: A meta-analysis. Meth Find Exp Clin Pharmacol 18(suppl B): 15-18, 1996.
22. Clement DL: Management of venous edema: Insights from an International Task Force. Angiology 51:13-17, 2000.
23. Mestres P, Rodríguez L, Erill S, et al: Modification by calcium dobesilate of histamine effects on capillary ultrastructure. Experientia 416:633-641, 1975.
24. Brunet J, Finer J-C, Garay RP, et al: In vitro antioxidant properties of calcium dobesilate. Fund Clin Pharmacol 12:205-212, 1998.
25. Graber R, Farine J-C, Losa GA: Calcium dobesilate protects human peripheral blood mononuclear cells from oxidation and apoptosis. Apoptosis 3:41-49, 1998.
26. Suschek C, Kolb H, Kolb-Bochofen V: Dobesilate enhances endothelial nitric oxide synthase activity in macrovascular and microvascular endothelial cells. Br J Pharmacol 122:1502-1508, 1997.
27. Sinzinger H, Rauscha F, Vinazzer H: Platelet function and prostaglandins in patients with peripheral vascular disease treated with calcium dobesilate. Prostagl Leukotr Med 29:1-9, 1987.
28. Hasslacher Ch, Kopischke HG, Búrklin E: Inhibition of the incurred synthesis of capillary basement membrane in diabetic rats in vivo. Vasa 10:148-150, 1981.
29. Leite E, Mora M, Faria de Adreu J, et al: Effect of calcium dobesilate on the blood-retinal barrier in the early diabetic retinopathy. Int Ophthalmol 14:81-88, 1990.
30. Michal M, Giessinger N: Effect of calcium dobesilate and its interaction with aspirin on thrombus formation in vivo. Thromb Res 40:215-226, 1985.
31. Gloviczki P, Fowl RJ, Hollier LH, et al: Prevention of platelet deposition by ibuprofen and calcium dobesilate in expanded polytetrafluoroethylene vascular grafts. Am J Surg 150:589-592, 1985.
32. Michal M, Gotti C: Effect of calcium dobesilate on platelet function. Thromb Res 51:593-605, 1988.
33. Heicrich H, Gerke E, Nekarda H: Inhibition of platelet aggregation under calcium dobesilate. Arzneimittel-Forschung 33:580-582, 1983.
34. Pfliegler G, Boda Z, Udvardy M, et al: Effect of calcium dobesilate treatment on haemostasis and serum lipids in diabetic patients. Acta Ther 12:71-79, 1986.
35. Vinazzer H, Hachen HJ: Influence of calcium dobesilate (Doxium®) on blood viscosity and coagulation parameters in diabetic retinopathy. Vasa 16:190-192, 1987.
36. Költringer P, Eber O, Rothlauer W, et al: Calcium dobesilate and its effects on hemorheology and microcirculation. Int J Clin Pharmacol Ther Toxicol 26:500-502, 1988.
37. Guerrini M, Pieragalli D, Acciavatti A, et al: Calcium dobesilate, haemorheology, fibrinolysis and endothelium. New prospects in the prevention of diabetic microangiopathy. A study of clinical pharmacology. Clin Ther 129:271-286, 1989.
38. Androulakis G, Panoysis PA: Plethysmographic confirmation of the beneficial effect of calcium dobesilate in primary varicose veins. Angiology 40:1-4, 1989.
39. Ernst E, Marshall M: Improvement of reduced erythrocyte flexibility through calcium dobesilate. Results of a pilot study. Múnch Med Wochenschr 126:125-126, 1984.
40. Barras J, Graf C: Hyperviscosity in diabetic retinopathy treated with Doxium (calcium dobesilate). Vasa 9:161-164, 1980.
41. Salama B, Brodsky I, Rubinstein M, et al: Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy. Ophthalmic Res 17:131-138, 1985.
42. Casley-Smith JR: The influence of tissue hydrostatic pressure and protein concentration on fluid and protein uptake by diaphragmatic initial lymphatics; effect of calcium dobesilate. Microcirc Endothelium Lymphatics 2:385-415, 1985.
43. Piller NB, Browning J: Effect of calcium dobesilate on the functional capabilities of mesenteric lymphatics in the guinea pig. Res Exp Med 167-172, 1986.
44. Piller NB: The lymphagogue action of calcium dobesilate on the flow of lymph from the thoracic duct of anesthetized and mobile guinea pigs. Lymphology 21:124-127, 1988.
45. Baricevic J: Does calcium dobesilate (Doxium®) improve the microcirculation and the musculovenous pump in patients with varicose veins? Vasa 9:240-245, 1980.
46. Hachen HJ, Lorenz P: Double-blind clinical and plethysmographic study of calcium dobesilate in patients with peripheral microvascular disorders. Angiology 33:480-487, 1982.
47. Jochens D, Stegmann W: Calcium dobesilate in the treatment of phlebopathies of the lower limbs. Results from 80 medical practices. Therapie Woche 33:4559-4562, 1983.
48. Múhleder J, Ohner W, Duma S: Perioperative treatment of patients with varicose veins using calcium dobesilate. Wien Med Wochenschr 138:569-573, 1988.
49. Widmer L, Bilnad L, Barras JP: Doxium® 500 in chronic venous insufficiency: A double-blind placebo-controlled multicentre study. Int Angiol 9:105-110, 1990.
50. Pecchi S, De Franco V, Damiani P, et al: Calcium dobesilate in the treatment of chronic venous insufficiency of the lower limbs. A double-blind clinical trial. Clin Ther 132:409-417, 1990.
51. Angehrn F, on behalf of the Swiss study group: Efficacy and safety of calcium dobesilate in patients with chronic venous insufficiency: An open-label, multicenter study. Curr Ther Res 56:346-357, 1995.
52. Fischer H, ed. Venenleiden (Tubinger Studie). Munich: Urban & Schwarzenberg, 1989.